Plate Nº 28 · recorded October 10, 2026
Science Policy & FundingReported finding
UK commits £54 million to biosecurity, AMR and animal vaccines
The UK government and UKRI will distribute £54 million across six research councils to tackle future epidemics, antimicrobial resistance and next-generation animal vaccines.
By Marcus Bennett3 min read580 words
In brief
- £54 million committed jointly by the UK government and UK Research and Innovation
- Six UK research councils will administer the funds: BBSRC, EPSRC, ESRC, MRC, NERC and STFC
- Three stated priorities: epidemic preparedness, antimicrobial resistance and next-generation animal vaccines
- The announcement was published in October 2026 and accompanied by a photo of a poultry-facility worker in protective gear
- UKRI did not publish a list of specific funded projects or timelines in the announcement

The UK government and UK Research and Innovation (UKRI) have jointly committed £54 million to strengthen the country's defences against biological threats — from future epidemics and drug-resistant infections to animal diseases.
The investment will be distributed across six UK research councils.
They are: the Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Sciences Research Council (EPSRC), Economic and Social Research Council (ESRC), Medical Research Council (MRC), Natural Environment Research Council (NERC) and Science and Technology Facilities Council (STFC).
What does the £54 million cover?
The package targets three overlapping priorities in biosecurity — a term for measures that protect humans, animals and the environment from biological threats.
The first priority is preparing for future epidemics. UKRI did not specify which projects will receive funding, but the stated aim is to improve the country's ability to detect and respond to fast-spreading outbreaks of infectious disease.
The second is antimicrobial resistance (AMR) — the process by which bacteria, viruses, fungi and parasites evolve to survive the drugs designed to kill them. The World Health Organization has called AMR one of the top global public health threats. Resistant infections make routine surgery, chemotherapy and caesarean births riskier, because doctors rely on working antibiotics to prevent complications.
The third is next-generation animal vaccines, which could protect livestock from diseases that may also threaten human health. "Next-generation" generally refers to platforms that use newer molecular techniques, such as mRNA or viral-vector designs, rather than traditional inactivated or weakened-virus shots.
Together, the three priorities reflect a "one health" approach, which treats human, animal and environmental health as a single connected system.
Why does this matter?
The announcement's accompanying image — a worker in a protective suit and boots inside a poultry facility — illustrates why.
Animal diseases can spread quickly through farming operations. Some, such as avian influenza, can also infect humans, with serious consequences for both public health and the food supply.
Antimicrobial resistance adds another layer of risk. Common infections that doctors treat easily today could become much harder to manage if the antibiotics used against them stop working.
The £54 million package is a relatively small investment compared to the economic cost of a major outbreak, but it could help researchers stay ahead of threats that cross from animals into people.
Who is paying?
The money comes jointly from the UK government and UKRI, the public body that funds research and innovation across the UK and oversees the six named research councils.
BBSRC leads work on bioscience, including animal health and agriculture. EPSRC supports engineering and physical sciences research. ESRC funds economic and social research. MRC backs medical research. NERC focuses on environmental science. STFC supports large national research facilities alongside physics and astronomy.
Each council will run its own funding calls within its specialty area, with UKRI coordinating the cross-council programme. UKRI says it expects the design to tackle threats that cut across disciplines. A new virus can move from a wildlife reservoir into livestock, then into farm workers, then into hospitals — a chain that touches biology, engineering, social behaviour and medicine at once.
What happens next?
UKRI has not yet published a full list of funded projects or their timelines. Researchers will likely learn which funding calls will open through individual research council websites in the coming months.
For now, the announcement signals the government's intent to keep biological threats high on the research agenda, even as other priorities compete for funding.
via UKRI News (Source)
More from Marcus Bennett
Nearby plates
- Scientists Map Three Weak Points in Antibiotic-Resistant Bacteria
- NSF and UKRI to Formalize Metascience Partnership Within Months
- NSF Plans Cuts to Core Science Programmes for White House Initiative
- UK's World-Leading Science Facilities Face £162m Funding Crisis
- NIH limits funding for research on health effects of public policy